Briefs: Alkem and Krsnaa Diagnostics
News

Briefs: Alkem and Krsnaa Diagnostics

Alkem has submitted a detailed corrective and preventive action (CAPA) plan to the regulator within the stipulated timelines.

  • By IPP Bureau | February 24, 2023

Closure of US FDA Inspection at Alkem's manufacturing facility located at Indore

The US FDA has issued an Establishment Inspection Report (EIR) for Alkem Laboratories Ltd's manufacturing facility located at Indore which was inspected from 01st July, 2022 to 07th July, 2022. In response to Form 483 issued by the US FDA containing one observation, the Company had submitted a detailed corrective and preventive action (CAPA) plan to the regulator within the stipulated timelines. The inspection has now been closed by the US FDA.

Krsnaa Diagnostics inaugurates Diagnostics Center under Uttar Pradesh CT Scan Project

As a part of the Agreement with Department of Medical, Health & Family Welfare, Government of Uttar Pradesh (GOUP) for providing CT Scan services in the 8 District Hospitals in the state of Uttar Pradesh, the Company has inaugurated its third Diagnostics Center of the above mentioned Agreement at Kanpur Nagar on 23rd February, 2023.

Upcoming E-conference

Other Related stories

Startup

Digitization